320 likes | 560 Views
항 류마티스 금제제의 분자적 작용기전. 주 대 명 가톨릭대학교 의과대학 생화학교실. Cytokine signaling pathway involved in inflammatory arthritis (Choy et al., 2001). NSAID Corticosteroids. Auranofin Parenteral gold Hydroxychloroquine Minocycline Sulfasalazine Azathioprine. Antirheumatic drugs. “ Second-line ” drugs
E N D
항 류마티스 금제제의 분자적 작용기전 주 대 명 가톨릭대학교 의과대학 생화학교실
Cytokine signaling pathway involved in inflammatory arthritis (Choy et al., 2001)
NSAID Corticosteroids Auranofin Parenteral gold Hydroxychloroquine Minocycline Sulfasalazine Azathioprine Antirheumatic drugs “Second-line” drugs (“Disease-modifying” or “Slow-acting”) “First-line” drugs Penicillamine Methotrexate Cyclosporin Chlorambucil Cyclophosphamide
항염작용을 나타내는 금제제. (1) gold sodium thiomalate, (2) gold thioglucose, (3) gold sodium thiosulfate, (4) gold sodium thiopropanosulfonate, (5) auranofin
Auranofin inhibits TNF gene expression by blocking NF-B activation
Proteins regulated by NF-B Proinflammatory cytokines TNF, IL-1, IL-2, IL-6, GM-CSF, M-CSF, G-CSF Chemokines IL-8, MIP-1 Gro-, -, and - Eotaxin Inflammatory enzymes iNOS, COX-2 5-Lipoxygenase cPLA2 Adhesion molecules ICAM-1, VCAM-1 E-selectin Receptors IL-2R ( chain) TCR ( chain)
NF-kB activation pathway LPS Virus TNF P NF-kB P P IKK P IkB IkB IkB IkB p50 p50 p50 p50 p65 p65 p65 p65 p50 p65 kB TNF
IkB kinase (IKK) • 500-900 kDa multi-subunit complex • Phosphorylates Ser 32 and 36 of IkBa • Inducible by NF-kB inducers • Contains IKKa,IKKb, andIKKg
IKK assay • Preparation of cell lysate • Immunoprecipitation with anti-IKK antibody • Incubation with [-32P]ATP and GST-IkB • Electrophoresis and autoradiography
NF-kB activation pathway LPS Virus TNF P NF-kB P P IKK P IkB IkB IkB IkB p50 p50 p50 p50 p65 p65 p65 p65 p50 p65 kB TNF
Metal compounds that inhibit IKK activity in vitro ID50 (M) Metal compounds ZnSO4 Aurothiomalate HgCl2 Aurothioglucose AuCl3 CuSO4 CoCl2 Na2Cr2O7 8.7 10.9 12.3 19.6 24.1 26.9 55.7 69.2 CaCl2, FeSO4, FeCl3, NiCl2, (NH4)6Mo7O24, CdCl2, cis-Pt(NH3)2Cl2 (cisplatin), and lead acetate were not effective.
Zn2+ and Cu2+ inhibit TNF synthesis by blocking IKK activation
Reducing and thiol-reactive agents modulate IKK activity in vitro
Proposed pathway for signal transduction by reactive cysteine modification (Finkel, 2000)
Oxidizing agents inhibit TNF-induced NF-B reporter gene expression
Oxidizing agents inhibit signal-induced IKK activation and in vitro IKK activity
LPS TNF PKC IKK P P IkB IkB p50 p50 p65 p65 Gold Oxidative Stress
Inhibition of homodimeric IKK and IKK by various thiol-modifying agents
Schematic representation of proposed model of IKK regulation by phosphorylation. (Karin, 2000)
KD LZ HLH IKK 165 178 191 IKK wtDLG Y A KDVDQG SL CT SFVG T LQ Y L APE IKK CASLAT S IKK SE ELCT E 166179 192 IKK wtDLG Y A KELDQG SL CT SFVG T LQ Y L APE IKK CA SLAT S IKK SE ELCT E IB Kinase(IKK) mutants
(A) IKK WT IKK CA Gold inhibits IKK through modification of Cys-179 in its activation loop Auranofin 03 10 30 03 10 30 (M) KA GST- IB IB IKK (B) IKK WT IKK CA Auranofin 03 10 30 03 10 30 (M) GST- IB KA IB IKK
H2O2 Diamide Cys-179 of IKK is necessary for the effect of H2O2 and diamide: kinase assay 0.3 1 3 0.3 1 (mM) TNF + + + + + + KA GST- IB IB IKK IKK-HA + + + + + + WT CA IKK-Flag + + + + + + WT CA
Conclusion • Gold and oxidizing agents inhibit NF-B and IKK activation by modifying Cys-179 of IKK. • Modification of Cys-179 of IKK by gold directly inhibits activated IKK.
The activation segment in inactive forms of different kinases